TNF and inflammatory bowel disease: In a French nationwide cohort, the incidence rates were 0.54, 0.41, and 0.95 per 1000 PY in IBD patients exposed to thiopurine monotherapy, anti-TNF monotherapy, and combination therapy, respectively.